信息获得新型冠状病毒抗原快速检测试剂盒的日本国内生产销售许可 ～产品名为“Quick Navi™ -COVID19 Ag”，8 月13 日开始向医疗机构销售～

IR信息FY2020 First Quarter Financial Results Presentation Summary

IR信息FY2020 First Quarter Presentation Materials

IR信息FY2020 First Quarter Summary of Consolidated Financial Statements

IR信息FY2020 First Quarter Summary of Consolidated Financial Results

信息新型冠状病毒简易检测试剂盒 申请日本国内生产销售许可

信息日本医療研究开发机构采用了本公司新型冠状病毒疫情有关的研究项目

IR信息Notice of Convocation of the 161st Ordinary General Meeting of Shareholders

IR信息Disclosure on the Internet Accompanying the Notice of Convocation of the 161st Ordinary General Meeting of Shareholders

IR信息FY2019 Financial Results Presentation Summary

IR信息FY2019 Summary of Consolidated Financial Results

IR信息FY2019 Summary of Consolidated Financial Statements

IR信息FY2019 Presentation Materials

信息申请埃博拉病毒快速检测试剂盒的日本国内制造销售许可

信息关于新型冠状病毒简易检测试剂盒的研发情况

信息Accelerating Research & Development of a Norovirus Vaccine

信息关于着手研发新型冠状病毒“COVID-19”简易检测试剂盒的通知

CSR信息在《CDP水安全2019》中获得“B”评价

IR信息FY2019 3rd Quarter Summary of Consolidated Financial Results

IR信息FY2019 3rd Quarter Summary of Consolidated Financial Statements

CSR信息在《CDP气候变化报告2019》中获得“A-”评价

信息新年致辞